| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| 10mg |
|
||
| Other Sizes |
|
| ln Vitro |
DMT1 blocker 2 (Compound 12f) does not cause any harm to HepG2 cells at 10 μM after 24 hours [1]. CYP3A4 activity is 44% inhibited by DMT1 blocker 2 (10 μM) [1].
|
|---|---|
| ln Vivo |
In an acute model of iron hyperabsorption, DMT1 blocker 2 (50 mg/kg; oral) inhibits the response of intestinal cells to iron-containing foods [1].
|
| Animal Protocol |
Animal/Disease Models: Weanling (3-4 weeks) rats were placed on a low-iron diet for four weeks [1]
Doses: 50 mg/kg Route of Administration: po (oral gavage), followed by iron challenge 1 hour later Experimental Results: Attenuated post-challenge serum iron increase. |
| References |
| Molecular Formula |
C16H13N3O
|
|---|---|
| Molecular Weight |
263.293923139572
|
| Exact Mass |
263.105
|
| CAS # |
1062648-63-8
|
| PubChem CID |
25016113
|
| Appearance |
White to yellow solid powder
|
| LogP |
2.7
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
20
|
| Complexity |
445
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
BKZBNMNLRQXSHY-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C16H13N3O/c20-16-15-12-6-2-1-5-11(12)8-9-13(15)18-19(16)14-7-3-4-10-17-14/h1-7,10,18H,8-9H2
|
| Chemical Name |
2-pyridin-2-yl-4,5-dihydro-3H-benzo[e]indazol-1-one
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~50 mg/mL (~189.90 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (9.50 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (9.50 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.7981 mL | 18.9905 mL | 37.9809 mL | |
| 5 mM | 0.7596 mL | 3.7981 mL | 7.5962 mL | |
| 10 mM | 0.3798 mL | 1.8990 mL | 3.7981 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
